Prostate MRI AI belongs in a human-in-the-loop workflow

As AI tools for prostate cancer detection on MRI move toward the clinic, an ESUR Prostate MRI Working Group report sets out how they should and should not be used. Deep-learning tools show high technical accuracy, but the report stresses a real gap between research performance and clinical readiness.

Its central position is a human-in-the-loop model: AI supports rather than replaces the radiologist, specifically to limit automation bias and the legal liability that follows an unchecked machine call. The group calls for prospective validation across multiple vendors, post-market surveillance to catch algorithmic drift, local validation before deployment, and proper user training.

For a department considering prostate MRI AI, this reframes adoption from a procurement decision to a governance one. Treat an AI output as a prompt to be confirmed, validate the tool on local data before trusting it, and monitor its performance over time rather than assuming it stays accurate.

• Use prostate MRI AI as support for the radiologist, not as a replacement reader.
• Guard against automation bias and the liability of acting on an unchecked AI call.
• Validate a tool on local data before deployment, not on vendor claims alone.
• Set up post-market surveillance to catch algorithmic drift over time.
• Provide user training before the tool enters the reporting workflow.

Why it matters

It moves AI adoption from a purchase decision to a governance one, placing responsibility for an AI-assisted report back with the radiologist.

Don't overread it

This is a working-group position report, not a trial; it guides safe adoption rather than reporting a new diagnostic performance.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.